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Role of macula densa nitric oxide and cGMP in the regulation Tubuloglomerular feedback (TGF) is a process by
of tubuloglomerular feedback. which the macula densa (MD) senses increases or de-
Background. Previous studies have suggested that nitric ox- creases in distal NaCl delivery and causes an increaseide (NO) produced within cells of the macula densa (MD)
or decrease in afferent arteriole (Af-Art) resistance, re-modulates tubuloglomerular feedback (TGF). We tested the
spectively. Thus, TGF participates in the regulation ofhypothesis that NO produced in the MD acts locally as an
autacoid to activate soluble guanylate cyclase and cGMP- glomerular filtration rate and distal NaCl delivery [1, 2].
dependent protein kinase in the MD itself. Although the mediators of TGF are not well identified,
Methods. Rabbit afferent arterioles (Af-Arts) and attached nitric oxide (NO) produced by the MD modulates theMD were simultaneously microperfused in vitro. The TGF
Af-Art vasoconstrictor effect of TGF [3, 4].response was determined by measuring the Af-Art diameter
Studies both in vivo and in vitro have suggested thatbefore and after increasing NaCl in the MD perfusate (from
17 mmol/L of Na and 2 of Cl to 65 mmol/L of Na and 50 of NO produced by neuronal NO synthase (nNOS) in the
Cl). TGF was studied before (control TGF) and after inhibiting MD partially inhibits TGF [3–5]. However, it is not
components of the NO-cGMP–dependent cascade in the tubu-
known whether NO produced by the MD acts as anlar or vascular compartment.
autacoid on the MD itself or diffuses to the Af-Art,Results. Increasing NaCl concentration in the MD perfusate
decreased the Af-Art diameter by 3.2 6 0.5 mm (from 18.5 6 where it causes vasodilation directly.
1.3 to 15.4 6 1.3 mm, P , 0.001). Adding a soluble guanylate Nitric oxide has been shown to act via a variety of
cyclase inhibitor (LY83583) to the MD increased TGF response second-messenger cascades, although most of its effects
to 6.3 6 1.1 mm (P , 0.031 vs. control TGF). Similarly, when
are mediated by cGMP [6]. NO stimulates generationcGMP-dependent protein kinase was inhibited with KT5823,
of cGMP not only in the vasculature but also in the renalTGF was augmented from 2.6 6 0.3 to 4.0 6 0.7 mm (P ,
0.023). An analogue of cGMP in the MD reversed the TGF- tubules, including the proximal tubule, thick ascending
potentiating effect of both 7-nitroindazole (7NI; an nNOS in- limb, and collecting duct [7–10]. However, whether NO
hibitor) and LY83583. Inhibition of MD guanylate cyclase did inhibits TGF via cGMP or some other mechanism hasnot alter the effect of acetylcholine (a NO-cGMP-dependent
not been studied.vasodilator) on the Af-Art. Perfusing the Af-Art with the guan-
Here we investigated the following hypotheses: (1)ylate cyclase inhibitor did not potentiate TGF, suggesting that
the effect of NO occurred at the MD via a cGMP-dependent NO produced in the MD by nNOS inhibits TGF via
mechanism. To determine whether the effect of NO in the MD activation of guanylate cyclase, which generates cGMP;
was entirely mediated by cGMP, TGF was studied after giving this in turn activates a cGMP-dependent protein kinase.(1) LY83583 or (2) LY83583 plus 7NI. Adding the nNOS inhibi-
(2) Most, if not all, of the effect of NO at the MD istor to the MD did not potentiate the TGF response further.
mediated by a cGMP-dependent mechanism, rather thanConclusions. We concluded the following: (1) NO produced
by the MD inhibits TGF via stimulation of soluble guanylate by other mediators; and (3) NO acts as an autacoid at
cyclase, generating cGMP and activating cGMP-dependent the level of the MD itself, rather than by diffusing to
protein kinase; (2) NO acts on the MD itself rather than by
the Af-Art. To test these hypotheses, microdissected rab-diffusing to the Af-Art; and (3) most, if not all, of the effect
bit Af-Arts with the MD attached were microperfusedof NO in the MD is due to a cGMP-dependent mechanism
rather than to other NO mediators. in vitro. The TGF response was determined by measur-
ing the Af-Art diameter before and after increasing NaCl
in the MD perfusate. TGF was studied before (controlKey words: renal function, neuronal NOS, kidney microcirculation,
guanylyl cyclase, afferent arteriole, vasodilation, autacoid. TGF) and after inhibiting components of the cGMP cas-
cade in the tubular or vascular compartment. We alsoReceived for publication August 24, 1999
studied whether an analogue of cGMP reverses the TGF-and in revised form March 31, 2000
Accepted for publication May 18, 2000 potentiating effects of nNOS or guanylate cyclase inhibi-
tors. To determine that drugs perfused into the tubularÓ 2000 by the International Society of Nephrology
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compartment did not act in the vascular compartment were 65.4 mmol/L Na and 50 mmol/L Cl. The MD was
perfused at a rate of 10 nL/min.or vice versa, we studied (1) the Af-Art vasodilator re-
sponse to acetylcholine (a NO-cGMP–dependent vaso- Bath volume was 1 mL. The bath consisted of MEM
containing 0.15% BSA and was exchanged continuouslydilator) when MD guanylate cyclase was inhibited and
(2) whether adding a guanylate cyclase inhibitor to the at a rate of 1 mL/min. Microdissection and cannulation
were completed within 90 minutes at 88C, after whichAf-Art perfusate would potentiate TGF. We found the
following: (1) NO produced by the MD inhibits TGF the bath was gradually warmed to 378C for the rest of
the experiment. Once the temperature was stable, a 30-via stimulation of soluble guanylate cyclase, generating
cGMP and activating cGMP-dependent protein kinase; minute equilibration period was allowed before taking
any measurements. Images were displayed at magnifica-(2) NO acts on the MD itself rather than by diffusing to
the Af-Art; (3) most, if not all, of the effect of NO in tions of up to 31980 and recorded with a video system.
Af-Art diameter was measured with a MetaMorph imagethe MD is due to a cGMP-dependent mechanism rather
than to other NO mediators; and (4) drugs perfused analysis system (Universal Imaging, West Chester, PA,
USA).into the tubular compartment do not act in the vascular
compartment and vice versa. LY83583, a guanylate cyclase inhibitor, was obtained
from Biomol Research Laboratories (Plymouth Meet-
ing, PA, USA); KT5823, a cGMP-dependent protein ki-
METHODS
nase inhibitor, was obtained from Kamiya Biomedical
Isolation and microperfusion of Af-Arts with MD Co. (Thousand Oaks, CA, USA), and dibutyryl-cGMP
attached were carried out as described previously [4]. was purchased from Sigma Chemical Co.
Briefly, young male New Zealand white rabbits were
given tap water ad libitum and fed standard rabbit chow; Statistics
they were then anesthetized with ketamine [50 mg/kg, Each separate experiment was approached in an anal-
intramuscularly (IM)], xylazine (50 mg/kg IM), and pen- ogous manner. The designs were repeated measures with
tobarbital (40 mg/kg IM) and were given an intravenous the same Af-Art being measured under different condi-
injection of heparin (500 U). The kidneys were removed tions. In all cases, a subset of all possible contrasts was
and sliced along the corticomedullary axis, and slices were specified in advance as being of primary importance. To
placed in ice-cold minimum essential medium (MEM; analyze a specific difference, a paired t-test was used.
Gibco, Grand Island, NY, USA) containing 5% bovine All tests were two-sided, and results are presented as
serum albumin (BSA; Sigma, St. Louis, MO, USA). Us- mean 6 SEM. For each experiment, comparisons of in-
ing a stereomicroscope (Olympus SZH, Tokyo, Japan) terest were considered a set, and Holm’s multiple com-
as described previously [4], a single superficial Af-Art parisons procedure was used to adjust for multiple test-
and its intact glomerulus from each rabbit were microdis- ing. P , 0.05 was considered significant.
sected together with adherent tubular segments consist-
ing of portions of the thick ascending limb, MD, and
RESULTSearly distal tubule. The microdissected sample was trans-
ferred to a temperature-regulated chamber mounted on Because NO stimulates cGMP production in other
nephron segments via soluble guanylate cyclase, we in-an inverted microscope (Olympus IMT-2) with Hoff-
mann modulation. Both the Af-Art and the end of either vestigated the effect of adding an inhibitor of soluble
guanylate cyclase to either the MD or Af-Art perfusatethe distal tubule or thick ascending limb were cannulated
with an array of glass pipettes as described previously [4]. on TGF as a means of elucidating the mechanism and
site of action of NO. First, we studied the effect of the sol-Intraluminal pressure of the Af-Art was measured by
Landis’s technique, using a fine pipette introduced into uble guanylate cyclase inhibitor LY83583 (1026 mol/L)
on TGF when added to the MD perfusate. When thethe lumen through the perfusion pipette. The Af-Art
was perfused with oxygenated MEM (95% O2; 5% CO2) MD perfusate was changed from low to high NaCl during
the control period, the Af-Art diameter decreased fromcontaining 5% BSA, and intraluminal pressure was
maintained at 60 mm Hg throughout the experiment. 18.5 6 1.3 to 15.4 6 1.3 mm, a reduction of 3.2 6 0.5
mm (N 5 6). When LY83583 was present in the MDThe MD was perfused with a modified Krebs-Ringer
bicarbonate buffer. The low-NaCl solution contained (in perfusate, changing NaCl from low to high caused the
diameter of the Af-Art to decrease from 18.7 6 1.3 tommol/L) 15 NaHCO3, 0.96 NaH2PO4, 0.24 Na2HPO4,
5 KHCO3, 1.2 MgSO4, 1.0 CaCl2, 5.5 glucose, and 1.0 Na 12.3 6 1.5 mm, a reduction of 6.3 6 1.1 mm (P , 0.031
compared with control TGF). Thus, TGF was signifi-acetate; thus, the final Na and Cl concentrations were
17.4 mmol/L Na and 2 mmol/L Cl. The high-NaCl solu- cantly enhanced by inhibiting soluble guanylate cyclase
in the MD (Fig. 1).tion had a similar composition except that 48 mmol/L
NaCl was added; thus, the final Na and Cl concentrations In a separate series of experiments, we studied
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Fig. 1. Effect of LY83583 (1026 mol/L), a sol-
uble guanylate cyclase inhibitor, on the tubu-
loglomerular feedback (TGF) response to
high NaCl [seen as a decrease in the afferent
arteriole (Af-Art) diameter]. (A) The macula
densa (MD) was perfused with a modified
Krebs-Ringer bicarbonate buffer containing
either low or high NaCl (N 5 6). When
LY83583 was added to the perfusate during
low NaCl perfusion, the diameter did not
change; however, during high-NaCl perfusion,
LY83583 potentiated TGF. (B) Symbols show
the TGF response: (h) control TGF; (j) TGF
when LY83583 was added to the MD. #P 5
0.031, changes in control TGF response vs.
changes in TGF response when LY83583 was
added to the MD.
increased diameter from 10.1 6 1.4 to 17.8 6 1.2 mm
(P 5 0.006); this increase was similar to that observed
in the absence of LY83583. These data indicate that
inhibiting MD soluble guanylate cyclase does not affect
NO-cGMP-induced dilation of the Af-Art.
We also measured the change in diameter induced by
high NaCl before and during perfusion of the Af-Art
with LY83583. When the MD perfusate was changed
from low to high NaCl during the control period, the
Af-Art diameter decreased by 3.0 6 0.9 mm (N 5 6; Fig.
3). After adding 1026 mol/L LY83583 to the lumen of
the Af-Art, the diameter did not change significantly.
When the MD perfusate was changed from low to high
Fig. 2. Vasodilator effect of acetylcholine (Ach) on preconstricted Af- NaCl in the presence of LY83583 in the Af-Art, the TGF
Arts, both before and during the addition of the soluble guanylate response was not significantly different from control (Fig.cyclase inhibitor LY83583 to the MD perfusate. Af-Arts were precon-
3). However, the concentration of LY83583 we usedstricted by adding norepinephrine (NE) to the bath. When acetylcholine
was added to the Af-Art perfusate, diameter increased significantly (*P 5 completely blocked acetylcholine-induced dilation in
0.006); however, the changes caused by acetylcholine in the absence or
preconstricted Af-Arts (before LY83583, from 6.1 6 1.6presence of LY83583 in the MD were the same. Abbreviations are:
MD, perfused into the macula densa; bath, superfused into the bath; to 12.8 6 1.4 mm; after LY83583, from 5.7 6 0.4 to 4.4 6
Af-Art, perfused into the afferent arteriole. 0.3 mm, N 5 3). These data indicate that inhibiting Af-
Art soluble guanylate cyclase does not affect TGF. When
taken all together, the data also indicate that when a
substance is perfused into the MD, it does not directlywhether the guanylate cyclase inhibitor LY83583 per-
affect the Af-Art and vice versa.fused into the MD inhibited the vasodilator effect of
Because inhibition of soluble guanylate cyclase in theacetylcholine on preconstricted Af-Arts. When the MD
MD augmented TGF, we next investigated whether in-was perfused with low-NaCl solution, adding 2 3 1027
creasing cGMP in the MD with a permeable analogue ofmol/L norepinephrine to the bath constricted Af-Arts
cGMP blunts TGF when MD nNOS or soluble guanylateto 59% of basal diameter (Fig. 2). Adding acetylcholine
cyclase is inhibited. When the MD perfusate was changed(1026 mol/L) to the arteriolar perfusate increased diame-
from low to high NaCl, the Af-Art diameter decreasedter from 11.4 6 1.1 to 17.6 6 1.2 mm (P 5 0.006). When
from 20.3 6 1.0 to 17.3 6 1.2 mm (N 5 7, P 5 0.006;it was removed, diameter returned to 10.1 6 1.2 mm.
Fig. 4A). Adding 1025 mol/L 7-nitroindazole (7NI) toAdding LY83583 to the low-NaCl MD perfusate did not
the high-NaCl solution (to inhibit nNOS) decreased theaffect diameter. When acetylcholine was now added to
the arteriolar perfusate in the presence of LY83583, it diameter further to 15.3 6 1.5 mm (P 5 0.001). When
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Fig. 3. (A) Changes in Af-Art diameter in-
duced by high NaCl before and during perfu-
sion of the Af-Art with the soluble guanylate
cyclase inhibitor LY83583 (N 5 6). (B) The
TGF responses in the absence (h) or presence
(j) of LY83583 in the Af-Art were similar.
Abbreviations are in the legend to Figure 2.
cGMP was added to the MD perfusate, the Af-Art diam- to high NaCl, the Af-Art diameter decreased from 18.4 6
eter increased to 18.8 6 1.3 mm (P , 0.004), thus re- 1.1 to 15.8 6 1.1 mm, a reduction of 2.6 6 0.3 mm (N 5
versing the effect of 7NI. Similar results were found 7). When the MD perfusate was changed from low to
when MD soluble guanylate cyclase was inhibited. When high NaCl in the presence of KT5823, the Af-Art diame-
the MD perfusate was changed from low to high NaCl, ter decreased from 17.9 6 1.0 to 13.6 6 1.5 mm, a reduc-
the Af-Art diameter decreased from 18.2 6 1.0 to 15.0 6 tion of 4.0 6 0.7 (P , 0.023 vs. control TGF; Fig. 6).
1.1 mm (N 5 6, P , 0.001). Adding LY83583 (1026 mol/L) Thus, inhibiting cGMP-dependent kinase in the MD aug-
further decreased the diameter from 15.0 6 1.1 to 12.0 6 mented TGF.
1.3 mm (P 5 0.001). When cGMP was added to the MD Because NO generated at the MD may blunt TGF
perfusate, the Af-Art diameter increased to 16.7 6 1.6 mm by activating other second-messenger cascades besides
(P , 0.002), reversing the effect of LY83583 (Fig. 4B). those dependent on cGMP, we investigated the effect
To rule out the possibility that changes in Af-Art diam- of 7NI on TGF while inhibiting MD soluble guanylate
eter reflect a direct effect of cGMP on the arteriole rather cyclase. When the MD perfusate was changed from low
than the MD cells, we tested whether adding cGMP to to high NaCl in the presence of LY83583, Af-Art diameter
the low-NaCl MD perfusate could dilate the arteriole. decreased by 3.8 6 0.8 mm (from 19.2 6 1.5 to 15.4 6
When the MD was perfused with low-NaCl solution and 1.3 mm, N 5 6). Adding 7NI to the MD perfusate in the
2 3 1027 mol/L norepinephrine was added to the bath, presence of LY83583 did not constrict the Af-Art further
the Af-Art was reduced to 52% of its original diameter (Fig. 7). In the presence of both inhibitors, when the
(P 5 0.005, N 5 5; Fig. 5). When cGMP was added MD perfusate was switched from low to high NaCl, the
only to the lumen of the MD while perfusing it with diameter decreased by 4.2 6 1.6 mm, not significantly
low-NaCl solution, the Af-Art diameter remained un- different from control (from 19.6 6 1.9 to 15.4 6 1.3 mm).
changed. Subsequently, when acetylcholine (1026 mol/L) Thus, the effect of inhibiting MD soluble guanylate cy-
was added to the lumen of the Af-Art, the diameter clase on TGF was not additive with inhibiting nNOS.
increased from 8.26 6 1.0 to 15.3 6 1.9 mm (P 5 0.005).
The data shown in Figures 4 and 5 indicate that directly
DISCUSSIONaugmenting MD cGMP can blunt TGF and that cGMP
Several studies have shown that NO generated by theperfused into the MD does not diffuse to the Af-Art in
MD blunts TGF [3–5]. NO produced by the MD couldsufficient quantities to alter its diameter (Fig. 5).
have several sites of action. First, it could act as an auta-cGMP may activate several enzymes, including cGMP-
coid, affecting processes in the MD itself. Alternatively,dependent protein kinase. To test whether activation of
it could act in the juxtaglomerular mesangial cells, whichcGMP-dependent protein kinase is a necessary step in
are most likely vital to transmission of the signal fromthe NO second-messenger cascade, we investigated the
the MD to the Af-Art. Finally, NO may diffuse from theeffect of the cGMP-dependent protein kinase inhibitor
MD to the Af-Art and thus cause it to dilate. To clarifyKT5823 (2 3 1026 mol/L) on TGF. During the control
period, when the MD perfusate was changed from low NO’s site of action, we first needed to show where soluble
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Fig. 5. Effect of dibutyryl cGMP (dbcGMP) on the Af-Art diameter
when added to the MD perfusate along with low NaCl (N 5 5). Norepi-
nephrine (NE) was added to the bath, and acetylcholine (Ach) was
added to the arteriolar perfusate. When dbcGMP was added to the MD,
it did not cause direct dilation of the Af-Art. The response to Ach was
also not affected. *P 5 0.006, Ach vs. NE plus dbcGMP. Abbreviations
are in the legend to Figure 2.
within the MD rather than by diffusing to the mesangium
or Af-Art. They also indicate that drugs perfused into
the tubular compartment do not act in the vascular com-
partment and vice versa.
Given that vasoconstrictors such as angiotensin aug-
ment TGF and vasodilators such as atrial natriureticFig. 4. Effect of dibutyryl cGMP (dbcGMP) on Af-Art diameter when
added to the MD perfusate along with high NaCl in the presence of factor (ANF) blunt TGF, one could predict that NO
7NI (A; N 5 7) or LY83583 (B; N 5 6). Both 7NI and LY83583
produced by the Af-Art would also blunt TGF becausepotentiated TGF response. Adding dbcGMP to the MD reversed this
effect. #P , 0.001, low vs. high NaCl; 1P , 0.001, high NaCl vs. high it is a vasodilator. However, directly blunting the activity
NaCl plus 7NI or LY83583; *P , 0.004, 7NI or LY83583 vs. 7NI or of soluble guanylate cyclase in the Af-Art and mesangial
LY83583 plus dbcGMP. MD, perfused into the macula densa.
cells by adding LY83583 to the arteriolar perfusate had
no effect on TGF. These data suggest that NO produced
by the endothelial cells of the Af-Art does not signifi-
cantly alter TGF.guanylate cyclase is activated by NO produced in the
Although it is well established that NO inhibits TGF,MD. Our data show that adding a soluble guanylate
how it does so remains unclear. To address this question,cyclase inhibitor to the tubular perfusate to block it in
we investigated the role of cGMP, NO’s second messen-the MD augments TGF; thus, NO produced in the MD
ger in many other tissues [7, 9, 11, 12]. Our data showblunts TGF by acting as an autacoid within this special-
that when soluble guanylate cyclase was blocked at theized plaque of cells rather than by diffusing to the Af-
MD, TGF was enhanced. Furthermore, when we in-Art and promoting vasodilation. These results cannot be
creased cGMP levels in the MD in the presence of 7NIexplained by the inhibitor diffusing to the Af-Art or
(to inhibit nNOS) or LY83583 (to inhibit guanylate cy-mesangial cells in sufficient quantities to alter NO-
clase), the Af-Art diameter increased. Finally, inhibitinginduced vasodilation, because (1) directly blunting solu-
cGMP-dependent protein kinase in the MD also en-ble guanylate cyclase in the Af-Art and mesangial cells
by adding LY83583 to the arteriolar perfusate had no hanced TGF. From these findings, we concluded that
NO stimulates soluble guanylate cyclase in the MD andeffect on TGF, and (2) perfusing the MD with an inhibi-
tor of soluble guanylate cyclase did not alter endothe- increases cGMP, which subsequently activates cGMP-
dependent protein kinase. Activation of cGMP-depen-lium-dependent relaxation of the arteriole by acetylcho-
line. Furthermore, perfusing the MD with dibutyryl dent protein kinase consequently diminishes another
process (as yet unknown) that is necessary for full expres-cGMP to augment cGMP levels in this segment blunted
TGF, but did not dilate Af-Arts preconstricted by nor- sion of TGF.
Although our data indicate that NO primarily acts viaepinephrine. Taken together, these data show that NO
produced by the MD blunts TGF by acting as an autacoid cGMP and cGMP-dependent protein kinase, the experi-
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Fig. 6. Effect of the cGMP-dependent pro-
tein kinase inhibitor KT5823 (2 3 1026 mol/L)
on TGF response to high NaCl (seen as a
decrease in the Af-Art diameter). (A) The
MD was perfused with a modified Krebs-
Ringer bicarbonate buffer containing either
low or high NaCl (N 5 7). When KT5823 was
added to the MD perfusate during low-NaCl
perfusion, the diameter did not change; how-
ever, during high-NaCl perfusion, KT5823 po-
tentiated TGF. (B) Symbols show the TGF
response: (h) control TGF; (j) TGF when
KT5823 was added to the MD. #P 5 0.023,
changes in control TGF response vs. changes
in TGF response in the presence of KT5823
in the MD. MD, perfused into the macula
densa.
Fig. 7. Effect of the neuronal nitric oxide syn-
thase (nNOS) inhibitor 7NI on TGF response
when MD guanylate cyclase was inhibited by
simultaneous perfusion of LY83583 (N 5 6).
Symbols are: (h) TGF in the presence of
LY83583; (j) TGF with LY83583 plus 7NI.
7NI did not potentiate TGF when MD guanyl-
ate cyclase was inhibited. MD, perfused into
the macula densa.
ments discussed previously in this article do not rule out caused a marked release of cGMP, which was reduced
by the NOS inhibitor NG-nitro-l-arginine [9]. Inhibitingthe possibility that another second-messenger cascade is
activated. To test this possibility, we examined the effect NOS with NG-monomethyl-l-arginine has been shown
to lead to a dose-dependent decrease in cGMP in renalof inhibiting MD nNOS on TGF after MD soluble guan-
ylate cyclase had been inhibited, but found that this had interstitial fluid and urine [7]. In addition, NO alters
nephron transport through a cGMP-linked mechanism.no effect on Af-Art diameter. These data suggest that
the effect of NO on the MD is mediated mainly by Roczniak and Burns showed that sodium nitroprusside
(SNP) inhibits Na transport via a cGMP-dependentcGMP.
Several other studies have shown that NO stimulates mechanism in the proximal tubule [10]. We have also
shown that NO inhibits transport of water in the corticalsoluble guanylate cyclase and augments cGMP genera-
tion in other tissues [7, 9, 13, 14]. Intravenous infusion collecting duct and Cl in the thick ascending limb by
stimulating cGMP production [15, 16].of NO donors significantly reduced mean arterial blood
pressure and urinary output and increased tubular secre- Increased intracellular cGMP may activate cGMP-
dependent protein kinase or affect other cGMP-dependenttion of cGMP [13]. In the isolated perfused rat kidney,
an injection of sodium nitroprusside or acetylcholine enzymes [11, 12, 17, 18]. cGMP-dependent protein kinase
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has now been implicated in a number of biologically MD; (2) NO activates soluble guanylate cyclase, in-
creases cGMP, and stimulates cGMP-dependent proteinimportant processes ranging from monitoring intracellular
Ca21 levels in smooth muscle cells to regulation of gene kinase, which in turn may inhibit transport by the MD;
and (3) the cGMP-dependent pathway is the primaryexpression. In addition, NO inhibits Na,K-ATPase activ-
ity in the proximal tubule through a mechanism involving second messenger activated by NO.
cGMP-dependent protein kinase [12]. We have reported
that agents that stimulate cGMP levels in the cortical ACKNOWLEDGMENTS
collecting duct decrease osmotic water permeability via This study was supported by National Institutes of Health grant
HL-28982 and by the National Kidney Foundation of Michigan.activation of cGMP-dependent protein kinase [15].
In most instances, NO’s effects are due to activation
Reprint requests to Oscar A. Carretero, M.D., Hypertension and
of guanylyl cyclase and increases in cGMP synthesis. Vascular Research Division, Henry Ford Hospital, 2799 West Grand
Boulevard, Detroit, Michigan 48202, USA.However, knowledge of NO effects independent of
cGMP is growing at a rapid rate. NO metabolites are
themselves highly reactive. Peroxynitrite (ONOO2) can REFERENCES
act as a physiological mediator (by activation of cyclo- 1. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard
LM, Mitchell KD: Paracrine regulation of the renal microcircula-oxygenase or other oxidases), or it may have prolonged
tion. Physiol Rev 76:425–536, 1996effects because of nitrosylation of tyrosine residues in
2. Briggs JP, Schnermann JB: Electrolyte excretion and electrolyte
proteins [19], interaction with nucleic acids, or induction balance: Whys and wherefores of juxtaglomerular apparatus func-
tion. Kidney Int 49:1724–1726, 1996of apoptosis [20]. Regulation of renin secretion involves
3. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R,different intracellular messengers; renin secretion is in-
Schmidt HHHW: Nitric oxide synthase in macula densa regulates
hibited by cGMP [21] and stimulated by cAMP, which glomerular capillary pressure. Proc Natl Acad Sci USA 89:11993–
11997, 1992appears to be a calcium-related pathway that could in-
4. Ito S, Ren Y: Evidence for the role of nitric oxide in macula densavolve protein kinase C [22].
control of glomerular hemodynamics. J Clin Invest 92:1093–1098,
Although our data indicate that NO produced by the 1993
5. Ichihara A, Inscho EW, Imig JD, Navar LG: Neuronal nitricMD acts as an autacoid via cGMP-dependent protein
oxide synthase modulates rat renal microvascular function. Am Jkinase, they do not address what process in the TGF
Physiol 274:F516–F524, 1998
response is affected. TGF is known to be initiated by 6. Biondi ML, Romero JC: Nitric oxide-mediated reactions stimulate
cGMP in the dog kidney. J Vasc Med Biol 2:294–298, 1990transport of Na, K, and Cl by the apical membrane Na/
7. Siragy HM, Johns RA, Peach MJ, Carey RM: Nitric oxide altersK/2Cl cotransporter. Using isolated perfused thick as-
renal function and guanosine 39,5-cyclic monophosphate. Hyper-
cending limbs in vitro, we have shown that NO inhibits tension 19:775–779, 1992
8. Berkelmans HS, Burton GA, Schipper J, De Vente J: Effects ofNaCl transport, suggesting that locally produced NO
atrial natriuretic factor, nitroprusside and acetylcholine on cGMPacting via an autocrine mechanism may directly affect
immunostaining in the isolated perfused rat kidney. Histochemistry
NaCl transport in the thick ascending limb [16]. In this 96:13–19, 1991
9. Heuze-Joubert I, Mennecier P, Simonet S, Laubie M, Verbeurensegment, NaCl absorption is initiated by Na/K/2Cl co-
TJ: Effect of vasodilators, including nitric oxide, on the releasetransport. Furthermore, Clemo, Feher, and Baumgarten
of cGMP and cAMP in the isolated perfused rat kidney. Eur J
showed that increased intracellular cGMP induced by Pharmacol 220:161–171, 1992
10. Roczniak A, Burns KD: Nitric oxide stimulates guanylate cyclaseANF inhibits Na/K/2Cl cotransporters in cardiomyo-
and regulates sodium transport in rabbit proximal tubule. Am Jcytes [23]. Although most studies indicate that NO has an
Physiol 270:F106–F115, 1996
inhibitory effect, some data suggest that NO stimulates 11. Dousa TP: Cyclic-39,59-nucleotide phosphodiesterases in the cyclic
adenosine monophosphate (cAMP)-mediated actions of vasopres-transport in the kidney. In vivo studies and kidney prepa-
sin. Semin Nephrol 14:333–340, 1994rations have shown that inhibiting NO results in natriure-
12. McKee M, Scavone C, Nathanson JA: Nitric oxide, cGMP, and
sis [24], suggesting that NO has an antidiuretic effect. In hormonal regulation of active sodium transport. Proc Natl Acad
Sci USA 91:12056–12060, 1994vitro in the rat medullary thick ascending limb, NO has
13. Nielsen CB, Eiskjaer H, Pedersen EB: Enhanced renal produc-been found to have a stimulatory effect on HCO32 ab- tion of cyclic GMP, and reduced free water clearance during so-
sorption [25], while in the rat proximal tubule it has a dium nitroprusside infusion in healthy man. Eur J Clin Invest
23:375–381, 1993biphasic effect [26]. The explanation for the discrepancy
14. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology,regarding the inhibitory effect of NO on transport and
pathophysiology, and pharmacology. Pharmacol Rev 43:109–142,
the stimulatory effect observed by others is not known. 1991
15. Garcia NH, Stoos BA, Carretero OA, Garvin JL: MechanismNevertheless, our results suggest that dynamic NO re-
of the nitric oxide-induced blockade of collecting duct water per-lease during TGF activation may inhibit MD transport,
meability. Hypertension 27:679–683, 1996
mitigate the TGF response, and serve as an intrinsic and 16. Plato CF, Stoos BA, Wang D, Garvin JL: Endogenous nitric
oxide inhibits chloride transport in the thick ascending limb. Amdynamic regulator of the TGF loop, directly counter-
J Physiol 276:F159–F163, 1999acting the TGF transmitter.
17. Kanagy NL, Charpie JR, Webb RC: Nitric oxide regulation of
In conclusion, the present studies indicate that (1) NO ADP-ribosylation of G proteins in hypertension. Med Hypotheses
44:159–164, 1995generated in the MD blunts TGF by acting within the
Ren et al: Macula densa NO regulates TGF2060
18. Lincoln TM, Cornwell TL: Intracellular cyclic GMP receptor synthesis in the juxtaglomerular cells. Curr Opin Nephrol Hyper-
tens 5:16–19, 1996proteins. FASEB J 7:328–338, 1993
19. Simon DI, Mullins ME, Jia L, Gaston B, Singel DJ, Stamler 23. Clemo HF, Feher JJ, Baumgarten CM: Modulation of rabbit
ventricular cell volume and Na1/K1/2Cl2 cotransport by cGMPJS: Polynitrosylated proteins: Characterization, bioactivity, and
functional consequences. Proc Natl Acad Sci USA 93:4736–4741, and atrial natriuretic factor. J Gen Physiol 100:89–114, 1992
24. De Nicola L, Blantz RC, Gabbai FB: Nitric oxide and angioten-1996
20. Lipton SA, Choi Y-B, Pan Z-H, Lei SZ, Chen H-SV, Sucher NJ, sin-II. Glomerular and tubular interaction in the rat. J Clin Invest
89:1248–1256, 1992Loscalzo J, Singel DJ, Stamler JS: A redox-based mechanism
for the neuroprotective and neurodestructive effects of nitric oxide 25. Good DW, George T, Wang DH: Angiotensin II inhibits HCO23
absorption via a cytochrome P-450-dependent pathway in MTAL.and related nitroso-compounds. Nature 364:626–632, 1993
21. Greenberg SG, He X-R, Schnermann JB, Briggs JP: Effect of Am J Physiol 276:F726–F736, 1999
26. Wang T: Nitric oxide regulates HCO23 and Na1 transport by anitric oxide on renin secretion. I. Studies in isolated juxtaglomeru-
lar granular cells. Am J Physiol 268:F948–F952, 1995 cGMP-mediated mechanism in the kidney proximal tubule. Am J
Physiol 272:F242–F248, 199722. Della Bruna R, Kurtz A, Schricker K: Regulation of renin
